-
公开(公告)号:US20180312523A1
公开(公告)日:2018-11-01
申请号:US15497414
申请日:2017-04-26
申请人: Ronald J. Biediger , Michele A. Benish , Lindsay Bonner Hardy , Vincent A. Boyd , Robert V. Market , Thomas P. Thrash , Brandon M. Young
发明人: Ronald J. Biediger , Michele A. Benish , Lindsay Bonner Hardy , Vincent A. Boyd , Robert V. Market , Thomas P. Thrash , Brandon M. Young
IPC分类号: C07D498/04 , C07D213/75 , C07D213/64 , C07D207/327 , C07C69/618 , C07D307/54 , C07D401/12 , C07D221/18 , C07D207/333 , C07C313/06 , C07D333/22 , C07D231/16 , C07D471/04 , C07D261/08 , C07D213/55 , C07D213/48 , C07D213/69 , C07C47/575 , C07C47/55 , C07D209/08 , C07D237/14
摘要: Provided herein are compounds and pharmaceutical compositions of formula I where R1, R2, R3, R4, R5 and R6 are as described herein. Also provided pharmaceutically acceptable salts or stereoisomers of these compounds. In addition methods are provided for inhibiting the binding of an integrin to treat various pathophysiological conditions.